Live Breaking News & Updates on Sputnikv Clinical Trial India

Sputnik V in India: Submit immunogenicity data, SEC tells Dr Reddy before nod for Russian vaccine
Premium
A Venezuelan health worker prepares a syringe with Russia s Sputnik V vaccine against the coronavirus disease (COVID-19), at a hospital, in Caracas, Venezuela February 22, 2021. REUTERS/Leonardo Fernandez Viloria NO RESALES. NO ARCHIVES
(REUTERS)
Share Via
Read Full Story
The Subject Expert Committee (SEC) of the Indian drug regulator on Wednesday took up an application by pharma giant Dr Reddy s Laboratories seeking emergency approval for Sputnik V, the Russia-developed Covid-19 vaccine, in the country.
The SEC didn t consider the request of Dr Reddy s application and has asked the firm to come back with immunogenicity data, news agency ....

Jammu And Kashmir , Amarinder Singh , Maruti Suzuki , Deepika Padukone , Oxford Covid , Army Day , Russian Direct Investment Fund , Russia Gamaleya National Research Institute Of Epidemiology , Oxford University , Serum Institute Of India , Chief Generalmm Naravane , New Delhi , Chief Minister Amarinder , Prisons Act , Drug Controller General , Serum Institute , K Series Dual Jet , Idle Start Stop , Gamaleya National Research Institute , Join Mint , Sputnik V , Sputnikv Covid Vaccine In India , Covid Vaccine India , Dr Reddy Application , Dr Reddy Laboratories , Sputnikv Clinical Trial India ,